We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Legal & General Global Healthcare & Pharmaceutical Class C - Income (GBP)

Sell:76.90p Buy:76.90p Change: 0.63p (0.81%)
Prices as at 26 February 2026
Sell:76.90p
Buy:76.90p
Change: 0.63p (0.81%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 26 February 2026
Sell:76.90p
Buy:76.90p
Change: 0.63p (0.81%)
Prices as at 26 February 2026
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 93.66%
UK Equities 5.88%
Cash and Equiv. 0.61%
Mutual Funds 0.00%
Other -0.15%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 10.32% USA Pharmaceuticals & Biotechnology
2 JOHNSON & JOHNSON 6.84% USA Pharmaceuticals & Biotechnology
3 ABBVIE 4.95% USA Pharmaceuticals & Biotechnology
4 ROCHE HOLDING AG 4.21% CHE Pharmaceuticals & Biotechnology
5 NOVARTIS AG 3.74% CHE Pharmaceuticals & Biotechnology
6 MERCK & CO INC(NEW) 3.45% USA Pharmaceuticals & Biotechnology
7 UNITEDHEALTH GROUP INCORPORATED 3.30% USA Health Care Providers
8 ASTRAZENECA 3.10% GBR Pharmaceuticals & Biotechnology
9 THERMO FISHER SCIENTIFIC 2.76% USA Medical Equipment & Services
10 NOVO NORDISK A/S 2.37% DNK Pharmaceuticals & Biotechnology

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account